There is evidence to suggest that IL-8 and myeloperoxidase (MPO) are biomarkers in the CF sputum at different stages of lung inflammation, such that IL-8 correlates with exacerbations, and MPO and IgG degradation correlates with lower FEV1% score [39]. The gene discussed is CXCL8; the disease is inflammatory response.